JGUA
STJ

John G. Ullman & Associates’s St Jude Medical STJ Stock Holding History

John G. Ullman & Associates’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-73,568
Closed -$5.9M – 126
2016
Q4 		$5.9M Hold
73,568
– – 1.24% 26
2016
Q3 		$5.87M Sell
73,568
-11,966
-14% -$966K 1.21% 27
2016
Q2 		$6.67M Buy
85,534
+12,675
+17% +$904K 1.37% 24
2016
Q1 		$4.01M Buy
72,859
+50,669
+228% +$2.76M 0.94% 34
2015
Q4 		$1.37M Sell
22,190
-434
-2% -$27.4K 0.3% 79
2015
Q3 		$1.43M Sell
22,624
-1,200
-5% -$85.6K 0.34% 76
2015
Q2 		$1.74M Sell
23,824
-1,800
-7% -$130K 0.33% 87
2015
Q1 		$1.68M Sell
25,624
-1,900
-7% -$126K 0.32% 80
2014
Q4 		$1.79M Sell
27,524
-525
-2% -$33.8K 0.34% 76
2014
Q3 		$1.69M Sell
28,049
-300
-1% -$19.6K 0.32% 82
2014
Q2 		$1.96M Sell
28,349
-900
-3% -$58.3K 0.36% 78
2014
Q1 		$1.91M Sell
29,249
-1,550
-5% -$101K 0.35% 80
2013
Q4 		$1.91M Sell
30,799
-400
-1% -$23.2K 0.36% 73
2013
Q3 		$1.67M Sell
31,199
-300
-1% -$15.4K 0.34% 73
2013
Q2 		$1.44M Buy
+31,499
New +$1.36M 0.3% 78

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

John G. Ullman & Associates's STJ Position: Q1 2017 in Review

John G. Ullman & Associates sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 73,568 shares — an estimated $5.9M sold.

John G. Ullman & Associates first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $6.67M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • John G. Ullman & Associates reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • John G. Ullman & Associates sold 73,568 St Jude Medical shares in Q1 2017, an estimated $5.9M.
  • John G. Ullman & Associates first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • John G. Ullman & Associates's St Jude Medical position peaked at $6.67M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on John G. Ullman & Associates's 13F filing for Q1 2017, filed 25 Apr 2017.